A

Active Director Director DIN 06937477
DIN 06937477 First appointment Dec 2014 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2014
Shareholding value •••• Premium profile

About Ambujam

Data last updated:

Ambujam is a Director at Sai Jyothi Herbal Pharmaceuticals Private Limited (since 2014). The company operates in Chemicals. Sai Jyothi Herbal Pharmaceuticals Private Limited reported revenue of ₹16.2 Lakh (FY 2024).

DIN 06937477
Primary Designation Director
Industry Chemicals
First Appointment 10 Dec 2014
Oldest Company Age 11 yrs
Largest company Sai Jyothi Herbal Pharmaceuticals Private Limited · ₹16.2 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director10 Dec 20142014₹16.2 Lakh (FY 2024)Active

Directorship timeline

Open interactive timeline →
Sai Jyothi Herbal Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Ambujam

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ambujam

Ambujam currently holds 1 directorship: Sai Jyothi Herbal Pharmaceuticals Private Limited (Director, since 10 Dec 2014, revenue ₹16.2 Lakh (FY 2024)).

Ambujam was first appointed on 10 Dec 2014 as Director at Sai Jyothi Herbal Pharmaceuticals Private Limited.

The current boards of Ambujam's companies include Azhakath Kodoly Sivasankaran (Sai Jyothi Herbal Pharmaceuticals Private Limited), Sruthi Sivan Elayadath Vapatt (Sai Jyothi Herbal Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available